The following is a summary of “A Prospective Crossover Study Comparing Six Current Generation Supraglottic Airway Device's ...

ResMed’s strong demand for AirSense 11 boosts its earnings outlook. Learn why RMD stock is undervalued with growth ...

Brown, who suffers from multiple sclerosis and cancer, said life as a disabled person in the UK is 'impossible' ...

For patients with OSA, sleep surgery is associated with a significantly reduced risk for MVA compared with CPAP therapy or no treatment.

An implant for sleep apnea is one of the few CPAP alternatives. This article compares hypoglossal nerve stimulation and ...

According to a recent report by Future Market Insights (FMI), the global airway management devices market is projected to experience significant growth, reaching USD 2.2 billion by 2033, up from USD 1 ...

Sleep apnea affects over 29 million Americans, with Obstructive Sleep Apnea (characterized by pauses in breathing during ...

but the impact of nasal continuous positive airway pressure (CPAP) therapy is unclear. Methods: We performed a long-term follow-up study of 168 patients with OSAS who had begun receiving CPAP ...

Medicare may cover medically necessary deviated septum surgery, but there are specific rules and exclusions to be aware of.

ResMed beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea, a common sleep disorder.

Rating for ResMed stock climbed into a higher percentile, rising to 72, up from 68 the day before. The upgrade puts ResMed not far beneath a key benchmark. Market research shows that the ...